Detalhe da pesquisa
1.
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
J Antimicrob Chemother
; 72(1): 268-272, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27707990
2.
Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study.
Antimicrob Agents Chemother
; 60(7): 4387-90, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27139477
3.
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Clin Infect Dis
; 60(10): 1462-71, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670823
4.
Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactam.
Antimicrob Agents Chemother
; 58(4): 2249-55, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24492369
5.
Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.
Antimicrob Agents Chemother
; 58(9): 5350-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982069
6.
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE).
Open Forum Infect Dis
; 10(7): ofad314, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496612
7.
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron.
Open Forum Infect Dis
; 10(6): ofad279, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351456
8.
Pharmacokinetics and safety of intravenous ceftolozane-tazobactam in healthy adult subjects following single and multiple ascending doses.
Antimicrob Agents Chemother
; 56(6): 3086-91, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450972
9.
Response to Spellberg and Brass.
Clin Infect Dis
; 62(4): 526, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486708
10.
Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis.
Pediatr Infect Dis J
; 39(9): 814-823, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639465
11.
Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
Ann Pharmacother
; 43(7): 1211-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19584384
12.
Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study.
EBioMedicine
; 40: 574-582, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638863
13.
Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo-Controlled, Multiple-Dose Study.
Clin Pharmacol Drug Dev
; 7(4): 382-391, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29517862
14.
Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infections.
J Clin Pharmacol
; 55(2): 230-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196976
15.
Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology.
Clin Infect Dis
; 38(1): 92-8, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14679454
16.
Thrombocytopenia associated with linezolid therapy.
Clin Infect Dis
; 34(5): 695-8, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11803505
17.
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.
Clin Infect Dis
; 37(12): 1643-8, 2003 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14689346
18.
In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
Diagn Microbiol Infect Dis
; 42(4): 269-71, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12007445
19.
Antimicrobial resistance in swine and chickens fed virginiamycin for growth promotion.
J Microbiol Methods
; 55(3): 739-43, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14607416
20.
Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registry.
Am J Geriatr Pharmacother
; 8(6): 551-61, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21356504